Physician profile
Anjan Kumar
NPI 1447460142
$4,229.29
in general payments reported to CMS, 2019-2025
23 companies · $709 in 2025
The $709 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $793 · 2020: $136 · 2021: $159 · 2022: $474 · 2023: $937 · 2024: $1,021 · 2025: $709.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,388 · Education: $280.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,387.84 |
| Education | $280.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $755.42 | 2019-2025 | Tezspire, Fasenra, Breztri |
| Genzyme Corporation | $665.55 | 2023-2025 | |
| Glaxosmithkline, LLC. | $449.31 | 2019-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Inogen, INC. | $420.89 | 2022-2025 | Inogen One G5 Oxygen Concentrator - Bluetooth, Inogen One G3 Oxygen Concentrator |
| United Therapeutics Corporation | $365.40 | 2019-2025 | Tyvaso |
| Actelion Pharmaceuticals US, INC. | $286.81 | 2019-2025 | Opsumit, Uptravi, Opsynvi |
| Regeneron Healthcare Solutions, INC. | $212.65 | 2021-2024 | Dupixent |
| Harmony Biosciences LLC | $195.54 | 2021-2025 | Wakix |
| Boehringer Ingelheim Pharmaceuticals, INC. | $136.30 | 2019-2025 | Ofev, Spiriva Respimat |
| Abiomed | $131.50 | 2024 | Impella |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $101.00 | 2019 | |
| Sanofi-Aventis U.S. LLC | $99.95 | 2023 | |
| Mylan Specialty L.P. | $98.31 | 2022-2023 | Yupelri |
| Intuitive Surgical, INC. | $73.96 | 2025 | |
| Insmed, INC. | $42.60 | 2025 | Brinsupri, Arikayce |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Verona Pharma, INC. | $37.17 | 2025 | Ohtuvayre |
| Baxter Healthcare | $34.80 | 2024-2025 | Hillrom - Monarch Airway Clearance System |
| Inspire Medical Systems, INC. | $26.64 | 2023 | Inspire |
| Edwards Lifesciences Corporation | $24.78 | 2022 | |
| Sunovion Pharmaceuticals INC. | $19.90 | 2019 | |
| Amgen INC. | $19.61 | 2023 | Tezspire |
| Vyera Pharmaceuticals, LLC | $17.59 | 2021 | |
| Portola Pharmaceuticals, LLC | $13.61 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anjan Kumar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.